At Spartha Medical, collaboration and bio-intelligence are at the heart of our mission to develop groundbreaking solutions that transform industries and improve lives. By drawing inspiration from nature, we create smart, adaptive coatings designed for versatility, customization, and optimized safety. …
Bioface project wins RHU for facial reconstruction in oncology
As part of France 2030, the BIOFACE project, led by Professor Agnès Dupret-Bories in Toulouse, is the winner of the Santé 2023 call for university hospital research projects (RHU). BIOFACE has been awarded funding of up to 4.395 million euros (wave 6). This project…
find by category
Spartha Supports October Rose & Movember: United for Cancer Prevention
Prevention is Key: A Simple Step to Better Health At the end of each year, the months of October and November are marked by two major awareness campaigns: Pink October and Movember. These initiatives aim to draw attention to breast …
Launch of Project KISSMat
Launch of Project KISSMat The KISSMat project was officially launched a few months ago with the objective of identifying new antimicrobial solutions for the medical, cosmetic, and food sectors. KISSMat brings together several entities from the Grand Est region, that …
Advancing Innovation Through Collaborative Projects: Spartha Medical’s Vision in Action
At Spartha Medical, collaboration and bio-intelligence are at the heart of our mission to develop groundbreaking solutions that transform industries and improve lives. By drawing inspiration from nature, we create smart, adaptive coatings designed for versatility, customization, and optimized safety. …
SPARTHA Medical joined the France Biotech network
Who are we? SPARTHA technology develops coatings based on natural biopolymers with antimicrobial, antiviral, and anti-inflammatory properties. Our main ambition is to protect medical devices and all types of surfaces from infectious risks by offering easy-to-apply and multifunctional coating solutions. …
Laureate of the EIC Accelerator
The EIC Accelerator is the European Innovation Council’s (EIC) programme for SMEs. Launched by the European Commission in September 2019 in its pilot phase ahead of Horizon Europe. The EIC aims to stimulate Europe’s economic growth by enabling visionary and …
Events and workshops
Annual Conference of the European Society for Biomaterials (ESB): A hub for Medical Innovation
The Annual Conference of the European Society for Biomaterials (ESB): A hub for Medical Innovation Every year, researchers, educators, clinicians, and industry representatives gather at the European Society for Biomaterials (ESB) Annual Conference to exchange knowledge and discoveries in the …
BIOFACE Project wins RHU for Oncology Facial Reconstruction
BIOFACE Project wins RHU for Oncology Facial Reconstruction As part of France 2030, the BIOFACE project, led by Professor Agnès Dupret-Bories in Toulouse, is the winner of the Health 2023 call for projects for university hospital research (RHU). BIOFACE has …
The value of coatings for medical devices
The value of coatings for medical devices Developments in medical technology require the use of medical devices. However, these medical devices can be the source of infections acquired in health care settings such as hospitals. What is a medical …
Basement membrane properties and their recapitulation in organ-on-chip applications
New review Drug discovery and toxicology is a complex process that involves considerable basic research and pre-clinical evaluation. These rely heavily on animal testing, which often fails to predict the results of human trials due to species differences. Coupled with ethical concerns …
Why are bacteria resistant to antibiotics?
Why are bacteria resistant to antibiotics? Did you know? 26 billion – the annual cost of antibiotic-resistant infections to US healthcare(1) Antibiotics still not used properly Antibiotics are drugs that fight an infection caused by bacteria by preventing it from …
How to prevent antibiotic resistance?
What is antibiotic resistance? Antibiotic resistance, is defined as the ability of a bacterium to become insensitive to the action of one or more antibiotics. This phenomenon is the result of repeated exposure to antibiotics. When many bacteria survive more …
Prevent the transmission of Covid-19 in hospitals
Prevent the transmission of Covid-19 in hospitals Since its outbreak in 2019, the last coronavirus-related disease (COVID-19) has spread around the world. In addition to its global impact, COVID-19 has alerted the healthcare community about the danger and harm of …
Spartha Supports October Rose & Movember: United for Cancer Prevention
Prevention is Key: A Simple Step to Better Health At the end of each year, the months of October and November are marked by two major awareness campaigns: Pink October and Movember. These initiatives aim to draw attention to breast …
Corporate social Responsibility: SPARTHA Medical
Corporate social Responsibility: SPARTHA Medical What does this mean for businesses? Corporate Social Responsibility (CSR) has been an increasingly important topic in the corporate world over the last years. It is a wide concept that can take many forms depending …